Address
Email address
Phone number
Website
https://www.caymaneurope.comCayman Europe OÜWe manufacture high quality biochemicals, assay kits, antibodies, and recombinant proteins and offer contract services for custom chemical synthesis/analysis, assay development/screening, and drug discovery.
Name
Cayman Europe OÜ
Registry code
11100176
VAT number
EE100948143
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
31.01.2005 (20)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
46901 - Non-specialised wholesale trade
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Peeter Vahtramäe
| - | Person competent to receive procedural documents | - | |
| Kirk Michael Maxey
| - | Board member | - | |
| KEVELT AS 10418580 | - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Maxey Cosmetics OÜ 12668418 | - | Person competent to receive procedural documents | - |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 1 085 679.03 € | 141 502.54 € | 29 617.2 € | 5 |
| 2024 Q3 | 834 544.67 € | 26 798.69 € | 28 673.46 € | 5 |
| 2024 Q2 | 980 648.51 € | 25 648.85 € | 27 328.19 € | 5 |
| 2024 Q1 | 820 846.21 € | 26 614.45 € | 28 320.4 € | 5 |
| 2023 Q4 | 796 561.51 € | - | 23 995.27 € | 4 |
| 2023 Q3 | 1 013 538.69 € | 26 240.94 € | 28 018.99 € | 4 |
| 2023 Q2 | 867 752.06 € | - | 22 177.35 € | 4 |
| 2023 Q1 | 825 747.54 € | - | 23 577.36 € | 4 |
| 2022 Q4 | 632 872.43 € | - | 17 136.42 € | 4 |
| 2022 Q3 | 720 968.62 € | - | 35 391.08 € | 3 |
| 2022 Q2 | 800 427.89 € | 21 817.34 € | 23 366.61 € | 4 |
| 2022 Q1 | 544 604.09 € | - | 21 540.81 € | 4 |
| 2021 Q4 | 518 084.08 € | - | 19 025.09 € | 4 |
| 2021 Q3 | 467 092.9 € | 19 246.01 € | 20 865.8 € | 4 |
| 2021 Q2 | 514 855.74 € | 13 384.41 € | 14 510.88 € | 4 |
| 2021 Q1 | 428 746.65 € | 13 805.04 € | 14 843.42 € | 3 |
| 2020 Q4 | 444 433.34 € | - | 12 500.98 € | 3 |
| 2020 Q3 | 387 584.3 € | 14 236.69 € | 15 294.84 € | 3 |
| 2020 Q2 | 468 662.12 € | 10 952.79 € | 11 919.6 € | 3 |
| 2020 Q1 | 558 098.43 € | 13 459.87 € | 14 177.4 € | 3 |
